The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature

AF Carvalho, MS Sharma, AR Brunoni… - Psychotherapy and …, 2016 - karger.com
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment
for major depressive disorders and are considered to be safer than tricyclic agents. In this …

A review of systemic medications that may modulate the risk of glaucoma

A Wu, AP Khawaja, LR Pasquale, JD Stein - Eye, 2020 - nature.com
With increasing longevity, patients are developing more and more chronic diseases that
require treatment with medications. Yet, it is not fully understood the extent by which these …

American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …

WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

What is the evidence regarding the safety of new obesity pharmacotherapies

J Vidal, L Flores, A Jiménez, A Pané… - International Journal of …, 2024 - nature.com
The use of gut-hormone receptors agonists as new therapeutic options for obesity and some
of its related comorbidities, such as type 2 diabetes, has resulted in an unprecedented …

A review of ocular complications associated with medications used for anxiety, depression, and stress

PA Constable, D Al-Dasooqi, R Bruce… - Clinical …, 2022 - Taylor & Francis
This review of commonly prescribed psychotropic drugs aims to update the clinician on
possible ophthalmic side effects that may include dry eye, diplopia, mydriasis, and cataracts …

Psychopharmacological treatment, intraocular pressure and the risk of glaucoma: a review of literature

AM Ciobanu, V Dionisie, C Neagu, OM Bolog… - Journal of Clinical …, 2021 - mdpi.com
Through the years, the available psychopharmacological treatments have expanded with
numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like …

Anticonvulsant efficacy in Sturge-Weber syndrome

EH Kaplan, EH Kossoff, CD Bachur, M Gholston… - Pediatric …, 2016 - Elsevier
Objective We analyzed individuals with epilepsy due to Sturge-Weber syndrome to
determine which anticonvulsants provided optimal seizure control and which resulted in the …

Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis

M Nourredine, L Jurek, M Auffret, S Iceta, G Grenet… - CNS …, 2021 - cambridge.org
BackgroundTo assess the efficacy and safety of topiramate in treating binge eating disorder
(BED), using a systematic review and meta-analysis of the available randomized clinical …

Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended …

B Halpern, MC Mancini - Expert Opinion on Drug Safety, 2017 - Taylor & Francis
Introduction: Few studies on combination therapies for the treatment of obesity had been
conducted until recently, when two fixed-dose combinations, bupropion-naltrexone ER fixed …

Association of drugs with acute angle closure

KI Na, SP Park - JAMA ophthalmology, 2022 - jamanetwork.com
Importance Acute angle-closure (AAC) glaucoma is a sight-threatening disease and can
reportedly occur in association with various drugs. Objective To identify drugs that are …